These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 4355974)

  • 21. Epstein-Barr virus in Burkitt's lymphoma and nasopharyngeal carcinoma. Antibodies to EBV associated membrane and viral capsid antigens in Burkitt lymphoma patients.
    Gunvén P; Klein G; Henle G; Henle W; Clifford P
    Nature; 1970 Dec; 228(5276):1053-6. PubMed ID: 4320656
    [No Abstract]   [Full Text] [Related]  

  • 22. Nasopharyngeal carcinoma and Epstein-Barr virus. II. Clinical course and the anti-VCA antibody.
    Lynn T; Tu S; Hirayama T; Kawamura A
    Jpn J Exp Med; 1973 Apr; 43(2):135-44. PubMed ID: 4352112
    [No Abstract]   [Full Text] [Related]  

  • 23. [Distribution of EBV-VCA and EA antibody in the general population in a high incidence area of nasopharyngeal carcinoma].
    Liu YX
    Zhonghua Zhong Liu Za Zhi; 1983 Sep; 5(5):337-9. PubMed ID: 6317314
    [No Abstract]   [Full Text] [Related]  

  • 24. Nasopharyngeal mucosal changes in EB virus VCA-IgA antibody positive persons.
    Li EJ; Tan BF; Zeng Y; Wang PZ; Zhong JM; Deng H; Zhu CS; Wei JN; Pan WJ
    Chin Med J (Engl); 1985 Jan; 98(1):25-30. PubMed ID: 2988864
    [No Abstract]   [Full Text] [Related]  

  • 25. [The diagnosis of nasopharyngeal carcinoma (author's transl)].
    Arnold W; Nakazima A; Wang YB; Vosteen KH; Brunner H; Göbel U
    HNO; 1980 Aug; 28(8):247-60. PubMed ID: 6254933
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IgA and nasopharyngeal carcinoma.
    Desgranges C; De-The G
    IARC Sci Publ (1971); 1978; (24 Pt 2):883-91. PubMed ID: 221410
    [No Abstract]   [Full Text] [Related]  

  • 27. High anti-EB virus titer in sera of patients with nasopharyngeal carcinoma: a small-scaled seroepidemiological study.
    Ito Y; Takahashi T; Kawamura A; Tu SM
    Gan; 1969 Jun; 60(3):335-40. PubMed ID: 4899471
    [No Abstract]   [Full Text] [Related]  

  • 28. Two-colour immunofluorescence studies on EBV-determined antigens.
    Klein G; Gergely L; Goldstein G
    Clin Exp Immunol; 1971 Apr; 8(4):593-602. PubMed ID: 4325123
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Nasopharyngeal cancer].
    Horiguchi S; Sawaki S
    Nihon Jibiinkoka Gakkai Kaiho; 1973 Jan; 76(1):86-7. PubMed ID: 4348039
    [No Abstract]   [Full Text] [Related]  

  • 30. [Immunological study of nasopharyngeal carcinoma].
    Tachibana T
    Nihon Ishikai Zasshi; 1971 Jun; 65(11):1387-98. PubMed ID: 4327018
    [No Abstract]   [Full Text] [Related]  

  • 31. Reactivity of radioiodinated serum antibody from Burkitt's lymphoma and nasopharyngeal carcinoma patients against culture lines derived from Bukrkitt's lymphoma.
    Inoue M; Klein G
    Clin Exp Immunol; 1970 Jul; 7(1):39-50. PubMed ID: 4320551
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased antibody to herpes simplex virus in patients with nasopharyngeal cancer.
    Palmer EL; Feorino PM; Martin ML
    J Infect Dis; 1972 Aug; 126(2):186-8. PubMed ID: 4340927
    [No Abstract]   [Full Text] [Related]  

  • 33. [Relationship between changes of 3 types of anti-EB virus antibodies in the serum of patients with nasopharyngeal cancer and their clinical courses].
    Terayama Y; Ueno M; Kamata N; Jinnai I; Sasaki Y
    Nihon Jibiinkoka Gakkai Kaiho; 1972 Oct; 75(10):1079-80. PubMed ID: 4120228
    [No Abstract]   [Full Text] [Related]  

  • 34. [Anti-EB virus titer in serum of patients with otorhinolaryngology cancer].
    Hosokawa T
    Nihon Jibiinkoka Gakkai Kaiho; 1970 Sep; 73(9):1533-6. PubMed ID: 4319400
    [No Abstract]   [Full Text] [Related]  

  • 35. A modified immunofluorescence test for detecting EB virus antibody.
    Vonka V; Kutinová L
    Acta Virol; 1972 May; 16(3):244-9. PubMed ID: 4113016
    [No Abstract]   [Full Text] [Related]  

  • 36. [Symptomatologic value of the assay of EBV antibodies in carcinoma of the nasopharynx].
    de Thé G
    J Fr Otorhinolaryngol Audiophonol Chir Maxillofac; 1983 Oct; 32(8):493-9. PubMed ID: 6319536
    [No Abstract]   [Full Text] [Related]  

  • 37. [Present status of infectious mononucleosis and Epstein Barr virus].
    Ducroix JP; Smail A; Vovan AT; Devauchelle B; Baillet J
    LARC Med; 1984 Mar; 4(3):161-3. PubMed ID: 6325836
    [No Abstract]   [Full Text] [Related]  

  • 38. Sensitivity of Epstein-Barr virus (EBV) producer and non-producer human lymphoblastoid cell lines to superinfection with EB-virus.
    Klein G; Dombos L; Gothoskar B
    Int J Cancer; 1972 Jul; 10(1):44-57. PubMed ID: 4122458
    [No Abstract]   [Full Text] [Related]  

  • 39. Malaria antibody levels in patients with nasopharyngeal carcinoma.
    Yadav M; Prasad U
    Southeast Asian J Trop Med Public Health; 1984 Jun; 15(2):234-7. PubMed ID: 6095462
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Epstein-Barr virus--a clinically relevant feature of nasopharyngeal carcinoma? (author's transl)].
    Wilmes E; Wolf H; Deinhardt F; Naumann HH
    Laryngol Rhinol Otol (Stuttg); 1981 Jan; 60(1):4-6. PubMed ID: 6261051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.